Rapid Micro Biosystems In... (RPID)
Rapid Micro Biosystems Statistics
Share Statistics
Rapid Micro Biosystems has 43.24M shares outstanding. The number of shares has increased by 0.87% in one year.
Shares Outstanding | 43.24M |
Shares Change (YoY) | 0.87% |
Shares Change (QoQ) | 0.47% |
Owned by Institutions (%) | 27.36% |
Shares Floating | 22.8M |
Failed to Deliver (FTD) Shares | 1.76K |
FTD / Avg. Volume | 0.32% |
Short Selling Information
The latest short interest is 113.59K, so 0.26% of the outstanding shares have been sold short.
Short Interest | 113.59K |
Short % of Shares Out | 0.26% |
Short % of Float | 0.48% |
Short Ratio (days to cover) | 0.96 |
Valuation Ratios
The PE ratio is -0.84 and the forward PE ratio is -1.83. Rapid Micro Biosystems's PEG ratio is 0.07.
PE Ratio | -0.84 |
Forward PE | -1.83 |
PS Ratio | 1.4 |
Forward PS | 1.9 |
PB Ratio | 0.52 |
P/FCF Ratio | -0.86 |
PEG Ratio | 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Rapid Micro Biosystems.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.61, with a Debt / Equity ratio of 0.08.
Current Ratio | 4.61 |
Quick Ratio | 3.46 |
Debt / Equity | 0.08 |
Debt / EBITDA | -0.12 |
Debt / FCF | -0.14 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $172.09K |
Profits Per Employee | $-287.66K |
Employee Count | 163 |
Asset Turnover | 0.29 |
Inventory Turnover | 1.04 |
Taxes
Income Tax | 22K |
Effective Tax Rate | -0.05% |
Stock Price Statistics
The stock price has increased by 185.45% in the last 52 weeks. The beta is 1.1, so Rapid Micro Biosystems's price volatility has been higher than the market average.
Beta | 1.1 |
52-Week Price Change | 185.45% |
50-Day Moving Average | 2.58 |
200-Day Moving Average | 1.32 |
Relative Strength Index (RSI) | 55.79 |
Average Volume (20 Days) | 545.1K |
Income Statement
In the last 12 months, Rapid Micro Biosystems had revenue of 28.05M and earned -46.89M in profits. Earnings per share was -1.08.
Revenue | 28.05M |
Gross Profit | 7.01M |
Operating Income | -49.92M |
Net Income | -46.89M |
EBITDA | -49.92M |
EBIT | -49.92M |
Earnings Per Share (EPS) | -1.08 |
Balance Sheet
The company has 16.91M in cash and 6.17M in debt, giving a net cash position of 10.74M.
Cash & Cash Equivalents | 16.91M |
Total Debt | 6.17M |
Net Cash | 10.74M |
Retained Earnings | -475.27M |
Total Assets | 98.17M |
Working Capital | 63.35M |
Cash Flow
In the last 12 months, operating cash flow was -44.15M and capital expenditures -1.36M, giving a free cash flow of -45.52M.
Operating Cash Flow | -44.15M |
Capital Expenditures | -1.36M |
Free Cash Flow | -45.52M |
FCF Per Share | -1.04 |
Margins
Gross margin is 24.99%, with operating and profit margins of -177.96% and -167.16%.
Gross Margin | 24.99% |
Operating Margin | -177.96% |
Pretax Margin | -167.08% |
Profit Margin | -167.16% |
EBITDA Margin | -177.96% |
EBIT Margin | -177.96% |
FCF Margin | -162.27% |
Dividends & Yields
RPID does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for RPID is $8, which is 192% higher than the current price. The consensus rating is "Buy".
Price Target | $8 |
Price Target Difference | 192% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Scores
Altman Z-Score | -4.42 |
Piotroski F-Score | 4 |